Artal Group S.A. - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 69 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2022$669
-99.9%
1,803,8580.0%0.04%
-2.6%
Q3 2022$902,000
-14.4%
1,803,8580.0%0.04%
-32.1%
Q2 2022$1,054,000
-17.9%
1,803,8580.0%0.06%
+3.7%
Q1 2022$1,284,000
-46.1%
1,803,8580.0%0.05%
-16.9%
Q4 2021$2,381,000
-42.6%
1,803,8580.0%0.06%
-30.1%
Q3 2021$4,149,000
-47.6%
1,803,8580.0%0.09%
-42.2%
Q2 2021$7,919,000
-39.5%
1,803,8580.0%0.16%
-30.3%
Q1 2021$13,096,000
+762.7%
1,803,858
+413.2%
0.23%
+600.0%
Q4 2020$1,518,000
+5.1%
351,5000.0%0.03%
-5.7%
Q3 2020$1,445,000
-34.9%
351,500
-5.0%
0.04%
-43.5%
Q2 2020$2,220,000
-26.3%
370,000
-7.5%
0.06%
-51.2%
Q1 2020$3,012,000
-37.4%
400,000
+14.3%
0.13%
-31.7%
Q4 2019$4,813,000
+15.8%
350,0000.0%0.19%
+11.4%
Q3 2019$4,158,000
-15.1%
350,0000.0%0.17%
-15.7%
Q2 2019$4,897,000350,0000.20%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
CHI Advisors LLC 4,081,972$9,388,0002.74%
RA Capital Management 11,028,722$25,366,0000.35%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$15,984,0000.31%
Avidity Partners Management LP 3,836,798$8,825,0000.20%
Casdin Capital, LLC 2,575,000$5,923,0000.15%
Vivo Capital, LLC 1,325,736$3,049,0000.14%
Artal Group S.A. 1,803,858$4,149,0000.09%
Eversept Partners, LP 569,581$1,310,0360.09%
GSA CAPITAL PARTNERS LLP 374,811$862,0000.09%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,315$2,480,0000.07%
View complete list of ORCHARD THERAPEUTICS PLC shareholders